[Phase I and pharmacokinetic study of KRN8602, a new morpholino anthracycline]

MLA

M, Tabata, et al. “[Phase I and Pharmacokinetic Study of KRN8602, a New Morpholino Anthracycline].” Gan to Kagaku Ryoho. Cancerchemotherapy, vol. 16, no. 7, July 1989. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........511a41a2d5f48e164f520e61eda117b6&authtype=sso&custid=ns315887.

APA

M, T., M, O., N, H., K, I., T, M., D, N., K, S., H, F., A, H., & N, M. (1989). [Phase I and pharmacokinetic study of KRN8602, a new morpholino anthracycline]. Gan to Kagaku Ryoho. Cancerchemotherapy, 16(7).

Chicago

M, Tabata, Ogawa M, Horikoshi N, Inoue K, Mukaiyama T, Nagamine D, Shinagawa K, Fukutani H, Hirano A, and Mizunuma N. 1989. “[Phase I and Pharmacokinetic Study of KRN8602, a New Morpholino Anthracycline].” Gan to Kagaku Ryoho. Cancerchemotherapy 16 (7). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........511a41a2d5f48e164f520e61eda117b6&authtype=sso&custid=ns315887.